Francesco Caponigro

7.8k total citations · 1 hit paper
101 papers, 4.6k citations indexed

About

Francesco Caponigro is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesco Caponigro has authored 101 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 35 papers in Otorhinolaryngology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesco Caponigro's work include Head and Neck Cancer Studies (34 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer Treatment and Pharmacology (19 papers). Francesco Caponigro is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer Treatment and Pharmacology (19 papers). Francesco Caponigro collaborates with scholars based in Italy, United States and Belgium. Francesco Caponigro's co-authors include Nicola Normanno, David Salomon, Caterina Bianco, Luigi Strizzi, Mario Mancino, Monica R. Maiello, Antonella De Luca, Gianfranco De Feo, Franco Ionna and Francesco Perri and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Francesco Caponigro

101 papers receiving 4.5k citations

Hit Papers

Epidermal growth factor receptor (EGFR) signaling in cancer 2005 2026 2012 2019 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidermal growth factor receptor (EGFR) signaling in cancer
    2005 1.6k citations Nicola Normanno, Antonella De Luca et al. Gene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Caponigro Italy 28 2.3k 2.0k 1.2k 594 592 101 4.6k
Faye M. Johnson United States 41 2.1k 0.9× 2.2k 1.1× 1.0k 0.8× 417 0.7× 532 0.9× 150 4.4k
Luis E. Raez United States 37 2.2k 1.0× 1.8k 0.9× 1.7k 1.4× 573 1.0× 427 0.7× 224 4.6k
Gerrit Los United States 33 1.7k 0.7× 1.8k 0.9× 1.0k 0.8× 838 1.4× 181 0.3× 94 4.1k
Nancy Hunter United States 46 2.7k 1.2× 2.0k 1.0× 1.7k 1.3× 620 1.0× 324 0.5× 123 6.7k
Antonio Jimeno United States 39 3.5k 1.5× 3.5k 1.7× 1.4k 1.1× 583 1.0× 459 0.8× 169 7.2k
Antonio Jimeno United States 36 3.1k 1.3× 2.3k 1.1× 1.4k 1.1× 552 0.9× 106 0.2× 128 5.2k
Anna Spreafico Canada 31 2.3k 1.0× 1.2k 0.6× 1.2k 1.0× 377 0.6× 274 0.5× 229 3.8k
Julie E. Bauman United States 36 2.7k 1.2× 2.6k 1.3× 1.6k 1.3× 1.2k 2.0× 1.8k 3.1× 140 6.6k
Y Ariyoshi Japan 31 3.2k 1.4× 2.0k 1.0× 2.8k 2.3× 416 0.7× 158 0.3× 127 5.5k
Jill Kolesar United States 37 1.8k 0.8× 2.0k 1.0× 936 0.8× 243 0.4× 107 0.2× 192 4.3k

Countries citing papers authored by Francesco Caponigro

Since Specialization
Citations

This map shows the geographic impact of Francesco Caponigro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Caponigro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Caponigro more than expected).

Fields of papers citing papers by Francesco Caponigro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Caponigro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Caponigro. The network helps show where Francesco Caponigro may publish in the future.

Co-authorship network of co-authors of Francesco Caponigro

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Caponigro. A scholar is included among the top collaborators of Francesco Caponigro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Caponigro. Francesco Caponigro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perri, Francesco, Giuseppina Della Vittoria Scarpati, Francesco Caponigro, et al.. (2019). <p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>. OncoTargets and Therapy. Volume 12. 1583–1591. 72 indexed citations
2.
3.
Perri, Francesco, Giuseppina Della Vittoria Scarpati, Franco Ionna, et al.. (2019). Clinical management of localized undifferentiated sinonasal carcinoma. Anti-Cancer Drugs. 30(3). 308–312. 4 indexed citations
4.
Caponigro, Francesco, Franco Ionna, Giuseppina Della Vittoria Scarpati, et al.. (2018). Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?. Anti-Cancer Agents in Medicinal Chemistry. 18(9). 1220–1227. 10 indexed citations
5.
Scarpati, Giuseppina Della Vittoria, Francesco Sabbatino, Soldano Ferrone, et al.. (2013). Multidisciplinary Approach to Patient with Malignant Melanoma. Anti-Cancer Agents in Medicinal Chemistry. 13(6). 887–900. 5 indexed citations
6.
Milano, Amalia, Francesco Perri, Andrea Ciarmiello, & Francesco Caponigro. (2011). Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?. Reviews on Recent Clinical Trials. 6(3). 259–265. 19 indexed citations
7.
Caponigro, Francesco, Amalia Milano, Raffaele Solla, et al.. (2008). A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Anti-Cancer Drugs. 19(7). 739–744. 18 indexed citations
8.
Milano, Amalia, et al.. (2007). Recent advances in the treatment of salivary gland cancers: Emphasis on molecular targeted therapy. Oral Oncology. 43(8). 729–734. 52 indexed citations
9.
Caponigro, Francesco, et al.. (2006). Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Current Opinion in Oncology. 18(3). 247–252. 16 indexed citations
10.
Milano, Amalia, et al.. (2006). New molecular targeted therapies in thyroid cancer. Anti-Cancer Drugs. 17(8). 869–879. 23 indexed citations
11.
Normanno, Nicola, Antonella De Luca, Caterina Bianco, et al.. (2005). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 366(1). 2–16. 1576 indexed citations breakdown →
12.
Normanno, Nicola, Caterina Bianco, Luigi Strizzi, et al.. (2005). The ErbB Receptors and their Ligands in Cancer: An Overview. Current Drug Targets. 6(3). 243–257. 225 indexed citations
13.
Caponigro, Francesco, et al.. (2005). New Drugs in Cancer Therapy, National Tumor Institute, Naples, 17???18 June 2004. Anti-Cancer Drugs. 16(2). 211–221. 26 indexed citations
14.
Caponigro, Francesco. (2002). Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002. Anti-Cancer Drugs. 13(8). 891–897. 21 indexed citations
15.
Avallone, Antonio, et al.. (2001). Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours. Cancer Chemotherapy and Pharmacology. 47(2). 113–116. 2 indexed citations
16.
17.
18.
Budillon, Alfredo & Francesco Caponigro. (1999). First international conference on new molecular targets for anticancer therapy, Naples, 22–23 June 1998. Anti-Cancer Drugs. 10(2). 249–256. 2 indexed citations
19.
Comella, P., Antonio Daponte, Rossana Casaretti, et al.. (1997). Fotemustine and dacarbazine plus recombinant interferon alpha2a in the treatment of advanced melanoma. European Journal of Cancer. 33(8). 1326–1329. 10 indexed citations
20.
Iaffaioli, R.V., Gaetano Facchini, Michele Santangelo, et al.. (1995). A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer. British Journal of Cancer. 72(5). 1256–1258. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faye M. Johnson Breakdown of academic impact, for papers by Luis E. Raez Breakdown of academic impact, for papers by Gerrit Los Breakdown of academic impact, for papers by Nancy Hunter Breakdown of academic impact, for papers by Antonio Jimeno Breakdown of academic impact, for papers by Antonio Jimeno Breakdown of academic impact, for papers by Anna Spreafico Breakdown of academic impact, for papers by Julie E. Bauman Breakdown of academic impact, for papers by Y Ariyoshi Breakdown of academic impact, for papers by Jill Kolesar
Rankless by CCL
2026